Adicet Bio to Participate in Fireside Chat at Jefferies Global Healthcare Conference
Stocks in this Quantisnow insightHealth Care
Historical context for ACET
Across the 10 sessions after earlier ACET headlines, the stock closed higher 6 times and lower 4 times, with a median move of 3.4% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | ACET | SPY |
|---|---|---|---|
| May 14, 2026 | Adicet Bio Reports First Quarter 2026 Financial Results and Provides Business Updates | +4.2% | +0.8% |
| May 5, 2026 | Jefferies resumed coverage on Adicet Bio with a new price target | +0.7% | +0.8% |
| Mar 13, 2026 | Adicet Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress | +2.4% | -0.6% |
| Jan 30, 2026 | Adicet Bio to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 | -6.0% | -0.3% |
| Jan 7, 2026 | Adicet Bio Provides Corporate Update and Highlights Expected 2026 Milestones | +5.0% | -0.3% |
| Dec 26, 2025 | Adicet Bio Announces Reverse Stock Split | +0.2% | -0.0% |
Quantisnow market dataNASDAQ
ACET
Adicet Bio Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2018
Get push alerts for ACET
Full ACET profile on Quantisnow Follow ACET and get a push notification the moment its next story breaks.